#stock-performance

#stock-performance

Bank of America shares gained 2.33% over the past month, resulting in a 15.02% year-to-date gain, and have increased nearly 40% since April's low.

HP Inc. reported a profit estimate of $0.74 per share for fiscal Q3 2025, which is a decline from the $0.83 per share in the same quarter last year.

Wall Street expects ServiceNow to report $3.12 billion in sales and $3.57 in earnings for the recent quarter, key indicators for investor sentiment.

IREN (NASDAQ: IREN) reported a record Q3 revenue of $148.1 million, a 172% increase year-over-year, driven by efficient Bitcoin mining and a 98% margin AI cloud segment.

Apple's recent leadership changes, particularly with the retirement of COO Jeff Williams and the exit of top AI executives, indicate a worrying trend for the company.

Meta Platforms has gained 23% on the year as of July 1, outperforming peers in the AI sector and showcasing potential beyond social media.

Lucid Group Inc. has begun production of its luxury electric SUV, the Gravity, which is anticipated to drive significant sales growth by 2025.

Verizon's stock performance stands out, gaining 9% amidst a market downturn, emphasizing the stability provided by its attractive dividend yield.

The markets are cautious as of mid-morning trading as they weigh this week's positive trade deal developments and easing inflation with signs of a cautious consumer.

"Leading the people of UnitedHealth Group has been a tremendous honor as they work every day to improve the health system, and they will continue to inspire me," Witty said.

The stock of PubMatic has plummeted over 80% since its peak in 2021, despite signs of underlying strength in its operational metrics.

Many investors are piling into a select group of dividend-paying companies that are very well-known. These big companies trade with a premium similar to growth stocks.

CDW's stock surged 7% after exceeding Q1 2025 earnings expectations, driven by strong demand for devices and cloud software.

Pfizer's stocks have struggled in 2025, down 23% from their yearly high, despite exceeding EPS expectations but falling short in revenue due to COVID product sales decline.